StockData
LeMaitre Vascular Inc logo

LeMaitre Vascular Inc (LMAT) stock

LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)

Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%

LeMaitre Vascular cash

Cash and short-term investments held at the end of each period.

LeMaitre Vascular's cash was $376.24M at Jun 30, 2026. For fiscal 2025 it was $359.12M, up 19.8% from the year before. Over ten years it grew 29.3% a year on average. The highest annual figure on record is $359.12M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$359.12M+19.8%
FY2024Dec 31, 2024$299.72M+185.2%
FY2023Dec 31, 2023$105.07M+27.1%
FY2022Dec 31, 2022$82.69M+18.2%
FY2021Dec 31, 2021$69.96M+159.3%
FY2020Dec 31, 2020$26.98M+128.9%
FY2019Dec 31, 2019$11.79M-55.2%
FY2018Dec 31, 2018$26.32M+37.8%
FY2017Dec 31, 2017$19.10M-21.4%
FY2016Dec 31, 2016$24.29M-11.5%
FY2015Dec 31, 2015$27.45M+46.9%
FY2014Dec 31, 2014$18.69M+27.1%
FY2013Dec 31, 2013$14.71M-10.6%
FY2012Dec 31, 2012$16.45M-18.3%
FY2011Dec 31, 2011$20.13M-11.0%
FY2010Dec 31, 2010$22.61M-2.5%
FY2009Dec 31, 2009$23.19M+45.9%
FY2008Dec 31, 2008$15.90M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$376.24M+17.8%
Q1 FY2026Mar 31, 2026$367.23M+21.4%
Q4 FY2025Dec 31, 2025$359.12M+19.8%
Q3 FY2025Sep 30, 2025$343.06M+176.9%
Q2 FY2025Jun 30, 2025$319.49M+182.5%
Q1 FY2025Mar 31, 2025$302.55M+179.4%
Q4 FY2024Dec 31, 2024$299.72M+185.2%
Q3 FY2024Sep 30, 2024$123.89M+27.7%
Q2 FY2024Jun 30, 2024$113.10M+25.4%
Q1 FY2024Mar 31, 2024$108.29M+33.7%
Q4 FY2023Dec 31, 2023$105.07M+27.1%
Q3 FY2023Sep 30, 2023$97.02M+21.7%
Q2 FY2023Jun 30, 2023$90.18M+19.2%
Q1 FY2023Mar 31, 2023$81.01M+14.3%
Q4 FY2022Dec 31, 2022$82.69M+18.2%
Q3 FY2022Sep 30, 2022$79.74M+18.9%
Q2 FY2022Jun 30, 2022$75.68M+251.3%
Q1 FY2022Mar 31, 2022$70.88M+201.3%
Q4 FY2021Dec 31, 2021$69.96M+159.3%
Q3 FY2021Sep 30, 2021$67.08M+129.1%
Q2 FY2021Jun 30, 2021$21.54M+7.8%
Q1 FY2021Mar 31, 2021$23.53M+115.0%
Q4 FY2020Dec 31, 2020$26.98M+128.9%
Q3 FY2020Sep 30, 2020$29.28M+149.8%
Q2 FY2020Jun 30, 2020$19.98M+50.6%
Q1 FY2020Mar 31, 2020$10.94M-25.9%
Q4 FY2019Dec 31, 2019$11.79M-55.2%
Q3 FY2019Sep 30, 2019$11.72M-41.7%
Q2 FY2019Jun 30, 2019$13.26M-32.5%
Q1 FY2019Mar 31, 2019$14.77M-35.2%
Q4 FY2018Dec 31, 2018$26.32M+37.8%
Q3 FY2018Sep 30, 2018$20.10M-46.4%
Q2 FY2018Jun 30, 2018$19.64M-34.8%
Q1 FY2018Mar 31, 2018$22.78M-11.7%
Q4 FY2017Dec 31, 2017$19.10M-21.4%
Q3 FY2017Sep 30, 2017$37.51M+8.3%
Q2 FY2017Jun 30, 2017$30.12M–
Q1 FY2017Mar 31, 2017$25.81M–
Q4 FY2016Dec 31, 2016$24.29M–
Q3 FY2016Sep 30, 2016$34.65M–

More LeMaitre Vascular figures

See a number that looks wrong?